David S. Ettinger, M.D., is Alex Grass Professor of Oncology and Professor of Medicine, Otolaryngology-Head and Neck Surgery, Obstetrics and Gynecology, and Radiation Oncology and Molecular Radiation Sciences at The Johns Hopkins University School of Medicine.

Dr. Ettinger received his medical degree from the University of Louisville School of Medicine in Louisville, Kentucky. His postgraduate training included an internship at Albany Medical Center Hospital in Albany, New York. He also completed fellowships at the Mayo Graduate School of Medicine in Rochester, Minnesota and The Johns Hopkins University School of Medicine in Baltimore. Dr. Ettinger is board certified in internal medicine and holds sub-specialty certification in medical oncology.

Dr. Ettinger has served as a consultant for dozens of organizations. He is widely published and has authored or co-authored more than 200 articles for journals such as The New England Journal of Medicine, the Journal of Clinical Oncology, and Cancer. He is a fellow of the American College of Physicians and is a member of the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, American Association for Cancer Research, Multinational Association of Supportive Care in Cancer, and the International Association for the Study of Lung Cancer. Dr. Ettinger is chair of the NCCN Non-Small Cell Lung Cancer Panel, Antiemesis Panel, and Occult Primary Cancers Panel. He is also the chair of the NCCN Guidelines Steering Committee. Dr. Ettinger is a member of the NCCN GIST Consensus Group; the NCCN Small Cell Lung Cancer Panel, Thymic Malignancies Panel, and Senior Adult Oncology Panel; the NCCN GIST and PET/CT Task Force; and the Non-Small Cell Lung Cancer DSEC. He is on the editorial board for JNCCN and part of the NCCN Cetuximab and Taxane Scientific Advisory Boards. In addition, Dr. Ettinger is a member of the NCCN Board of Directors and ORP Investigators Steering Committees.

Disclosure:

Has served on advisory boards for AstraZeneca, Bristol-Myers Squibb, Celgene, Daichi Sankyo, Eli Lilly, Eisai, Genentech, GlaxoSmithKline, ImClone, Merck, Novartis, Pfizer, Poniard, Prometheus, and Sanofi-Aventis